Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
FDA Grants Breakthrough Status to Praxis’s Relutrigine Post-EMBOLD Trial
Praxis Precision Medicines has been granted Breakthrough Therapy Designation (BTD) by the U.S. Food and Drug Administration (FDA) for relutrigine (PRAX-562)....
US FDA Approves EKTERLY® as First Oral On-Demand Treatment for HAE
KalVista Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY® (sebetralstat), a new oral plasma kallikrein inhibitor, for the treatment of acute attacks of hereditary angioedema (HAE)...
Hikma Gains FDA Approval for Novel TYZAVAN™, a Ready-to-Use Vancomycin Injection
Hikma Pharmaceuticals PLC has received approval from the U.S. Food and Drug Administration (FDA) for TYZAVAN™ (Vancomycin Injection, USP), a novel, ready-to-infuse form of the widely used antibiotic vancomycin. ...
Kelun-Biotech's Sac-TMT and Tagitanlimab Receives Breakthrough Therapy Designation
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has announced that its TROP2-targeting antibody-drug conjugate, sacituzumab tirumotecan, combined with the PD-L1 monoclonal antibody tagitanlimab, has been granted Breakthrough...
Innovent Biologics Receives Breakthrough Therapy Designation for Novel Lung Cancer Treatment
Innovent Biologics has been granted a second Breakthrough Therapy Designation by the Centre for Drug Evaluation (CDE), part of China’s National Medical Products Administration. ...
Cellectar Receives FDA Breakthrough Therapy Designation for Iopofosine I-131
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Cellectar Biosciences for its lead candidate, iopofosine I-131...
PharmAla Biotech Introduces Novel Phenesafe AI Platform to Discover New Phenethylamine Compounds
PharmAla Biotech Holdings, a biotechnology firm specialising in the research, development, and manufacture of LaNeo™ MDMA and new MDMA derivatives (MDXX class molecules), has officially launched its Phenesafe AI platform. ...
UT Health San Antonio Innovates Breakthrough in Drug Discovery
Researchers at UT Health have achieved a significant breakthrough through a novel concept known as "chemical endocytic medicinal chemistry," which aims to transform how drugs are designed for cellular uptake....
uniQure’s AMT-130 Receives FDA Breakthrough Designation for Huntington’s Treatment
uniQure’s investigational gene therapy, AMT-130, has received Breakthrough Therapy designation from the U.S. FDA for the treatment of Huntington’s disease, a rare and inherited neurodegenerative disorder with no approved therapies that alter its progression....
Oregon State University Researchers Discover Novel Drug Delivery Platform for Alzheimer’s and Brain Disorders
Researchers at Oregon State University have developed a method to deliver anti-inflammatory medicines across the blood-brain barrier, offering new possibilities for treating a range of conditions...
